4M1 Lymphoma, B cell & sentinel (Case 4) neoplastic area CD3 4X | Sentinel & Steroid Rx Lesions | MYELIN (IMMUNE-MEDIATED)

Washington University Experience | MYELIN (IMMUNE-MEDIATED) | Sentinel & Steroid Rx Lesions | 4M1 Lymphoma, B cell & sentinel (Case 4) neoplastic area CD3 4X

7M1,2 There is a substantial diffuse reactive T cell infiltration (CD3 IHC) in the same tissue area as the B-cell lymphoma (CD3 IHC)